TORNTPHARM.NSTORNTPHARM.NS
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
10.25%
↓ 25% below average
Average (9y)
13.66%
Historical baseline
Range
High:75.61%
Low:-8.18%
CAGR
-10.8%
Structural decline
| Period | Value |
|---|---|
| 2025 | 10.25% |
| 2024 | 2.13% |
| 2023 | 0.00% |
| 2022 | 5.95% |
| 2021 | -1.42% |
| 2020 | -8.18% |
| 2019 | 16.96% |
| 2018 | 6.48% |
| 2017 | 75.61% |
| 2016 | 28.80% |